Sobi - Swedish Orphan Biovitrum AB (publ) en las noticias
Acceso a terapias para enfermedades raras
Tamtam encontró 20 artículos recientes sobre Sobi - Swedish Orphan Biovitrum AB (publ).
- Swedish Orphan Biovitrum AB (publ) (SOBI.ST) stock price, news, quote and history
- Swedish Orphan Biovitrum AB (publ) (SOBI.ST) stock price, news, quote and history
- Swedish Orphan Biovitrum AB (publ) (OMXSTO:SOBI) Pays $75M As Innate Deal Becomes Effective
- Sobi and Innate announce partnership is now effective following completion of closing conditions
- Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome
- Sobi has completed an issue of class C shares
- Sobi has completed an issue of class C shares
- Sobi has completed an issue of class C shares
- Sobi has completed an issue of class C shares
- Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
- Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
- Lacutamab Moves Toward Planned Phase 3 Trial in Rare T-Cell Lymphoma
- Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
- The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company’s commitments under an incentive programme
- Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
- Have Insiders Sold Swedish Orphan Biovitrum Shares Recently?
- Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
- Have Insiders Sold Swedish Orphan Biovitrum Shares Recently?
- Guido Oelkers to step down as CEO of Sobi in the beginning of 2027
- Guido Oelkers to step down as CEO of Sobi in the beginning of 2027
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Sobi - Swedish Orphan Biovitrum AB (publ)?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares